Tg Therapeutics (TGTX) Profit After Tax (QoQ) (2011 - 2026)
Tg Therapeutics (TGTX) Profit After Tax (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Tg Therapeutics | 8.08 Bn | 8.00 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.15% |
| Dec 31, 2025 | -94.11% |
| Sep 30, 2025 | 1,286.79% |
| Jun 30, 2025 | 457.06% |
| Mar 31, 2025 | -78.31% |
| Dec 31, 2024 | 501.31% |
| Sep 30, 2024 | -43.60% |
| Jun 30, 2024 | 164.25% |
| Mar 31, 2024 | 25.73% |
| Dec 31, 2023 | -112.65% |
| Sep 30, 2023 | 339.30% |
| Jun 30, 2023 | -21.36% |
| Mar 31, 2023 | 50.00% |
| Dec 31, 2022 | -119.08% |
| Sep 30, 2022 | 11.58% |
| Jun 30, 2022 | 41.30% |
| Mar 31, 2022 | 26.06% |
| Dec 31, 2021 | -8.99% |
| Sep 30, 2021 | -9.10% |
| Jun 30, 2021 | 13.39% |